Clinical Trial Update: Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial exploring pembrolizumab with chemotherapy with or without radiation in small cell lung cancer has terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Small Cell Lung Cancer (SCLC) | Phase 2 | Status: TERMINATED | Results posted: 2021-11-16